Looking for a trusted research peptide source?
Amino Club offers 99%+ purity, independent lab testing and batch-specific COAs across its peptide catalog.
Save 20% with code NOW20 π
https://t.co/VEk0o2CHGx
Retatrutide is the triple agonist changing the
weight-loss conversation.
It targets GIP, GLP-1 and glucagon receptors.
Phase 2 produced up to 24.2% mean weight reduction at 48 weeks.
Explore trusted research options through our profile.
Best SARM for a clean bulk?
If the goal is lean size, strength and muscle fullness, LGD-4033 is still the most common pick.
RAD-140 = harder / drier look.
Ostarine = milder, controlled approach.
LGD still leads for clean bulk.
COA + batch info first. Always.
CHECK LINK IN BIO
Real Peptides Just Cut Their Whole Popular
Lineup in Half
Not a small clearance sale β this is their core lineup, all at 50% off:
Retatrutide β triple receptor GLP-1/GIP/glucagon, the fat loss compound everyone's asking about ($65-150)
BPC-157 β the healing baseline, gut + tissue repair ($45)
NAD+ β mitochondrial energy, the one people run year-round ($62.50-120)
Tesamorelin β only FDA-approved GHRH peptide on the market ($47.50)
MOTS-c β mitochondrial signaling, aging/metabolism angle ($45-140)
Real Peptides has built a name on 99%+ purity and third-party COAs, so this is a good window to stock up before pricing resets.
Here: https://t.co/iKsQLOyYqW
Research use only.
Most peptides in the longevity and body composition space are research compounds. Investigational. Grey area.
Tesamorelin is different.
FDA approved in November 2010 under the brand name Egrifta. The only GHRH analog with Phase III clinical trial data and formal FDA approval for a specific metabolic indication. That distinction matters.
How it works: Tesamorelin is a 44 amino acid synthetic analog of GHRH β the hormone your hypothalamus uses to signal the pituitary to release growth hormone. It maintains physiological pulsatile GH release. Not exogenous GH forcing supraphysiological levels. Your own system, amplified.
Phase III data (Falutz et al., LIPO-010): 2mg daily subcutaneous injection produced 15-18% visceral adipose tissue reduction at 26 weeks versus a 5% increase in the placebo group. Trunk fat, waist circumference, and waist-to-hip ratio all improved significantly. Triglycerides and total cholesterol improved in treated patients. Lean body mass increased by 1.42 kg.
2026 meta-analysis of five RCTs confirmed: 27.71 cmΒ² mean visceral fat reduction. 1.42 kg lean mass increase.
US search volume for tesamorelin has grown 49% in six months β from 90,500 monthly searches in September 2025 to over 135,000 by February 2026. The longevity and metabolic medicine community is paying attention.
FDA approved for HIV-associated lipodystrophy only. Off-label use in non-HIV populations is not FDA approved. Research use only.
Different peptides for different goals.
Recovery, fat loss, metabolism, skin, longevity β each has its own compounds and pathways.
Goal first.
Source quality always.
HERE: https://t.co/7W02JRPO66
Research peptide content and sourcing info.
Real Peptides consistently delivers β verified purity, proper shipping, full ingredient transparency.
Check them out below π π§¬
https://t.co/iCrEFmoz5k
Sleep & Testosterone
Bad sleep doesn't just make you tired.
It tanks your testosterone.
One week of sleeping 5 hours per night reduces testosterone levels by 10-15% in healthy young men. That's the equivalent of aging 10-15 years hormonally.
The mechanism: testosterone is primarily produced during sleep. Specifically during REM and deep sleep stages. Cut the sleep, cut the production window.
No supplement fixes a sleep deficit. Not zinc, not ashwagandha, not anything.
Sleep is the protocol.
Research use only.
5 Foods to Avoid on Reta or Any GLP-1
.....
Running Retatrutide, semaglutide, or tirzepatide?
Your protocol is only as good as what you eat around it.
GLP-1 class drugs slow gastric emptying. That's part of how they work. But it also means certain foods hit differently β and can make the experience significantly worse.
1. Fried and high-fat foods
Fatty foods slow stomach emptying even further. On top of GLP-1's existing delay β nausea, bloating, and indigestion. High-fat diets also slow drug absorption, reducing effectiveness.
White bread, white rice, pasta, sugary cereals. They spike blood sugar rapidly and counteract the glucose regulation the compound is working to establish. The worst choice when the whole point is metabolic control.
3. Carbonated drinks
Digestion is already slowed. Carbonation adds gas and bloating on top of that. Soda, sparkling water β minimize or eliminate during the active protocol.
4. High-sugar processed foods
Candy, pastries, energy bars. Rapid glucose spikes work directly against GLP-1 mechanism. They also tend to come with poor satiety β dangerous when appetite suppression is already doing the work.
5. Alcohol
GLP-1 medications enhance alcohol sensitivity. Lower food intake means alcohol hits faster and harder. Nausea risk increases significantly when combined with GI side effects already present during titration.
The compound does the heavy lifting. Don't undermine it with the wrong inputs.
Research use only.
.......
#retatrutide
5-Amino-1MQ β research compound studied for metabolic health and fat loss. Blocks NNMT enzyme, which plays a role in fat cell energy storage. Early data shows potential for body recomp and mitochondrial support. Often stacked with other metabolic peptides. π§¬
Retatrutide & Cardiovascular Markers
Everyone's focused on the weight loss numbers.
The cardiovascular data is what actually matters long-term.
TRIUMPH-1 and TRIUMPH-4 both tracked cardiometabolic markers as secondary endpoints. Here's what the numbers showed at 80 weeks:
Triglycerides β down 41%
Non-HDL cholesterol β down 24.2%
Systolic blood pressure β down 12.3 mmHg
hsCRP (inflammatory marker) β significant reduction Waist circumference β down 24.1 cm
TRIUMPH-4 added: systolic blood pressure down 14 mmHg at 12mg dose.
For context β a 14 mmHg drop in systolic blood pressure is double the effect of many dedicated blood pressure medications.
These aren't primary endpoints. TRIUMPH-1 wasn't designed as a cardiovascular outcomes trial. Fewer heart attacks and strokes hasn't been proven yet β that requires longer dedicated trials. TRIUMPH-3, the cardiovascular outcomes trial, is still running with results expected later in 2026.
What the data does show: meaningful improvement in every major cardiovascular risk marker measured.
The weight loss is the headline. The metabolic picture underneath it is the real story.
Research use only.
TB-500 (Thymosin Beta-4) β research peptide studied for tissue repair, recovery and inflammation reduction. Promotes cell migration and blood vessel growth. Popular in injury recovery protocols, often stacked with BPC-157. π§ͺ
You can eat enough protein and still lose muscle.
Chronically elevated cortisol breaks down tissue for fuel regardless of what's on your plate. It's not a nutrition problem β it's a recovery problem.
Training harder makes it worse if the stress load is already too high. The signal to build muscle and the signal to survive stress are running on the same system. One wins.
Most people optimizing their diet haven't touched their cortisol.